Workflow
West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum

"Our current expectation is that HVP component revenues will grow mid- to high-single digits in 2025, and we anticipate a continued mix shift to HVP in 2025 and beyond." Tom Werner/DigitalVision via Getty ImagesI am currently pursuing a BSc in Economics, Finance, and Data Science at Imperial College London and serve as the President of Imperial College Investment Society (ICIS), the #1 student business and finance society in the UK.My hands-on experience includes working end-to-end on live M&A deals at Eden ...